Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Monday, February 13, 2017
Neurocrine Biosciences and BIAL have entered into an exclusive licensing agreement for the development and commercialization of opicapone in North America. ONGENTYS® (opicapone) is a once-daily, peripherally-acting, highly-selective catechol-O-...
read more
Monday, February 13, 2017
Ferring Pharmaceuticals and Foresee Pharmaceuticals have entered into an exclusive worldwide development and option agreement to leverage Foresee’s proprietary and unique Stabilized Injectable Formulation platform (SIF) for the development of long ...
read more
Monday, February 13, 2017
Zenith Technologies has appointed David Staunton as director of global managed services to help meet increased demand for its automation and manufacturing execution system (MES) services.
read more
Wednesday, February 15, 2017
SGS is expanding its elemental analysis testing capabilities at its Villeneuve-la-Garenne, France laboratory. The site has invested in a new inductively coupled plasma mass spectrometry (ICP-MS) system, in a move to address the updated ICH Q3D ...
read more
Wednesday, February 15, 2017
Clintec has announced the launch of its new brand identity - reflected in their newly created website. This in part marks Clintec’s 20th anniversary and the achievement of significant milestones following another year of substantial growth, together ...
read more
Wednesday, February 15, 2017
Asterand Bioscience has announced a partnership with MolecularMD to combine MolecularMD’s expertise as a provider of molecular diagnostics products and services with Asterand Bio’s drug target and candidate validation capabilities.
read more
Wednesday, February 15, 2017
Ligand Pharmaceuticals has announced the appointment of Christel Iffland, Ph.D. as a Vice President of Antibody Technologies.
read more
Wednesday, February 15, 2017
X-Chem, Inc. has expanded its collaboration with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, to discover new drug leads for the treatment of inflammatory disease.
read more
Wednesday, February 15, 2017
ProTrials Research has announced the expansion of their suite of services to include data management. In response to the evolving needs of their clients, ProTrials has broadened their offering, adding both data management services and a variety of ...
read more
Friday, February 17, 2017
Pfizer CentreOne, a global contract manufacturing organization embedded within Pfizer, has expanded its fill-finish services to its Kalamazoo, Michigan (United States), site. Along with vial-filling of small molecules and biologics, the facility ...
read more
Friday, February 17, 2017
Ajinomoto North America, Inc., a wholly owned subsidiary of Ajinomoto Co., Inc., now offers to North American customers’ pharmaceutical-grade L-cystine that is produced using fermentation technology
read more
Friday, February 17, 2017
Catalent has completed the acquisition of Accucaps Industries Limited (Accucaps), the Canada-based developer and manufacturer of Over-the-Counter (OTC), high-potency and conventional pharmaceutical softgels. Financial details of the transaction have ...
read more
Friday, February 17, 2017
ICON plc has reported its financial results for the fourth quarter and full year ended December 31, 2016.
read more
Friday, February 17, 2017
Imprimis Pharmaceuticals has begun shipping its core sterile ophthalmic medications to select customers from its FDA-registered outsourcing facility without the need for a patient-specific prescription. Over the next few weeks Imprimis' flagship ...
read more
Friday, February 17, 2017
SYMBIOSIS Pharmaceutical Services is set to open an office in North America in response to continued demand from US-based biotechnology companies for its vial-filling expertise.
read more